The recent trial in a case now settled highlights the potential expansion of public nuisance claims under California law, and in large-scale public nuisance actions more broadly.
This article reviews several health care merger and acquisition (M&A) from 2022 and Q1 2023. Many of last year’s deals were underscored by significant ties to artificial intelligence (AI) technologies, a trend likely to become more prevalent going forward.
In the July issue of the ACC Observer, David Cambria shared his unique and broad perspective on legal operations' current trajectory. This column focuses on Cambria's career experience, which makes his insights worth contemplating.
In this multi-jurisdictional guide, explore an overview of key legal issues, rules and developments regarding litigation and dispute resolution across a range of jurisdictions.
This Quick Overview discusses how sports and entertainment employers that have noncompete agreements with their employees in the US, or are considering them, should respond to developments at the federal and state levels.
This guide from Latham & Watkins and KPMG is designed to provide a roadmap to help navigate the financial statement requirements of the US federal securities laws.
The journey from Delegation of Authority (DOA) to Contract Lifecycle Management System (CLM) is about marrying effective governance with technological solutions. By doing so, organizations can ensure not only a swift and reliable contract approval process but also adaptability to changing requirements over time.
Often overlooked are the impacts wildfires can have on oil and gas operations. The potential for wildfires to cause severe damage underscores the need for stringent fire safety protocols.
This articles provides steps oil and gas operators can take in preparation for and prevention of a wildfire.
Canada is an attractive market for pharmaceutical manufacturers. Most Canadian consumers have some form of drug coverage through government programs and/or private insurance. Below are ten patent and regulatory topics that in-house counsel need to know before bringing an innovative product to Canada.
Editor's note: This article was updated to reflect recent developments; the original version of this article was published on December 16, 2020.
The September 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this chart.